Ft. Lauderdale, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company focused on hemp cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices; has announced that its wholly owned subsidiary, Earth Science Pharmaceutical, Inc., has initiated a clinical prelaunch study for its MSN-2 medical device for the diagnosis of Chlamydia and Gonorrhea in women. The study will involve 60 female patients. The company has also announced that it has elected Dr. Michel Aubé as its new CEO and CSO (Chief Scientific Officer), as well as Nickolas Tabraue as President of both Earth Science Tech, Inc., and its wholly-owned subsidiary Earth Science Pharmaceutical, Inc.
This news follows the company’s August 24, 2016 announcement, “ETST Acquired the Assets and Business of BEO-ITS, Inc., a Canadian Biotech Company Specializing in Medical Devices, Tests and Vaccines for Sexually Transmitted Infections and/or Diseases.” This asset purchase agreement of BEO ITS, Inc., which was incorporated under ETST’s new wholly-owned subsidiary, Earth Science Pharmaceutical, Inc., included the employment of its CEO and principal owner, Dr. Aubé as its CEO.
“I’m honored and thrilled to be the CEO and CSO of both Earth Science Tech, Inc., and Earth Science Pharmaceutical, Inc., a company focused on the development of medical devices, testing processes, and vaccines for STIs (Sexually Transmitted Infections and/or Diseases).” stated Dr. Aubé. “I am also excited to announce that Earth Science Pharmaceutical has opened a clinical prelaunch study of its MSN-2 medical device for the diagnosis of Chlamydia and Gonorrhea which will allow us to acquire the final data we need to launch the product. I have personally been working with epidemiologist Dr. Lauren Azoulay on this new study, which will involve recruiting 20 women with Chlamydia and 40 women with Gonorrhea from private medical clinics for testing with our new MSN-2 medical device. The protocol, developed by Dr. Azoulay, will allow all physicians to understand the scope and the value of the new device. The protocol, with the results and the analyzed data, will be transmitted to the authorities once finished. This study will help Earth Science Pharmaceutical acquire all the necessary major regulatory approvals including; ISO 13485, FDA, and Health Canada. The results will be combined in a scientific report in the format of a Short Report or Rapid Communication and will be published in a selected scientific journal such the International Journal of STD & AIDS or Sexual Health.”
Dr. Aubé went on to say, “This small, but important study will also allow us to begin manufacturing Earth Science Pharmaceutical’s MSN-2 medical device and will provide the molecular diagnostic expertise that we need to market our MSN-2 device in all countries. I believe this data will be the final proof that our easy method for the self-collection of vaginal specimens is accurate for the diagnosis of Gonorrhea.”
The accuracy of the MSN-2 medical device for the diagnosis of women with Chlamydia has already been proven via a study of 510 female patients, which showed PCR testing results on paired samples to be identical for 493 (96.6%) of the 510 women. To view this study, visit Evaluation of a Modified Sanitary Napkin as a Sample Self-Collection Device for the Detection of Genital Chlamydial Infection in Women.
Using Earth Science Pharmaceutical’s new technology, a woman will be able to comfortably wear the non-invasive MSN-2 medical device (which is similar to a modified sanitary napkin but with a special filter) for 4 consecutive hours (when she is not menstruating), after which she will place the device in a special envelope packaged with the device and send it to a specific laboratory for testing. This new, simple to use technology means a woman will be able to easily take her own sample in the comfort of her home, instead of going to the doctor for an invasive swab, which can engender feelings of intrusion and/or embarrassment.
“We will be releasing more details with regards to the MSN-2 medical device shortly”, added Dr. Aubé. “I plan to build this company into a global leader in the development of low cost, non-invasive diagnostic tools, medical devices, and vaccines. We will have many exciting new developments to announce in the near future, pertaining to the medical and pharmaceutical industry as well as CBD (Cannabidiol).”
The global market for this type of testing is very large. Worldwide, the population of woman between the ages of 15 and 25 years is estimated to be more than 500,000,000. ETST’s target-market is all sexually active women in this age group, because the health authorities of many countries recommends that they should be tested for Chlamydia infections yearly to preserve their fertility and avoid severe complications such as cervical cancer. Per the World Health Organization, roughly 1 million new STI cases occur every day. Yearly, the number is about 131 million new cases of Chlamydia and 78 million of Gonorrhea.
The United States remains the largest medical device market in the world with a market size of around $148 billion, and it is expected to reach $155 billion by 2017. The U.S. market value represented about 43 percent of the global medical device market in 2015. U.S. exports of medical devices in key product categories identified by the Department of Commerce (DOC) exceeded $44 billion in 2015. There are more than 6,500 medical device companies in the United States, mostly small and medium-sized enterprises (SMEs). Read more at https://www.selectusa.gov/medical-technology-industry-united-states.
As previously announced, Earth Science Tech, Inc. (ETST) is focused on the science, research and studies of its High-Grade Hemp CBD Oil as a health and wellness, nutraceutical and dietary supplement. Feel free to view some of our Scientific Research and Data on Earth Science Tech (ETST) High Grade Hemp CBD (Cannabidiol) at http://earthsciencetech.com/scientific-research.
ETST invites all interested parties to contact the company at email@example.com to secure its "High Grade Hemp CBD (Cannabidiol) Oil" in bulk for wholesale, resale or distribution. From product formulating, mixing, labeling and launching ETST can do it all. ETST is always open to forming new strategic partnerships, joint ventures and/or supplying vendors, resellers and third party distribution companies with its High Grade Hemp CBD (Cannabidiol) Oil/Products at wholesale prices in order to better help supply consumers as well as the health and wellness markets on a large scale. You can view, research and purchase small quantities or bottles of ETST High Grade CBD (Cannabidiol) Rich Hemp Oil and/or Products at http://www.earthsciencetech.com/cbd-rich-hemp-oil.
ETST High Grade Hemp CBD is derived 100% from imported Grade-A European industrial hemp. ETST High Grade Hemp CBD Products contain hundreds of micronutrients (phytonutrients). Modern science has identified over 400 phytonutrients in various parts of the industrial hemp plant. These include hundreds of Terpenoids, Essential Oils and Antioxidants but perhaps the most dynamic are a group of compounds called Cannabinoids (phyto-cannabinoids) that are exclusively found in Hemp and one other place; our bodies. There are roughly 80 different phyto-cannabinoids, most prominently CBD, CBC, CBG, CBN, and most likely others yet to be effectively identified. In addition to the cannabinoids present in our industrial Hemp CBD Oil extracts, there are also many other types of natural molecules and “plant” chemical compounds such as amino acids, fatty acids (including omega 3 & 6), vitamins, flavonoids, ketones, nitrogenous compounds, alkanes, alcohols, glycosides, pigments and terpenes among other things. The most common terpenes in our Hemp CBD oils are Beta-caryophyllene, Caryophyllene Oxide, Myrcene, Terpinolene, a Bisabolol, a Pinene, Nerolidol, Ocimene and Phytol. Hemp oil contains more essential fatty acids than any other plant.
Humans are designed with a built-in Endocannabinoid System (ECS): Research shows that many scientists believe cannabinoids work synergistically to support the whole human endo-cannabinoid system (internal and natural human cannabinoid system). It is your body's way of communicating with itself and properly regulating the way every other body system functions from your brain to your toes. The Endocannabinoid System (ECS) has shown to control pain sensation, appetite, temperature regulation, stress reactivity, immune function, and sleep as well as other processes. Even more interesting is that muscle and fat tissue also utilize these receptors to control their processes. Consumers should think of the Endocannabinoid System as one of the body's main control and command centers for tweaking your metabolism's ability to react and adapt to the world around it. Like many other nutrients in our diet, Cannabinoids can become exhausted and in need of steady dietary replenishment. Scientific studies and data show that Hemp CBD (Cannabidiol) Oil as well as all micronutrients (phytonutrients) and phyto-cannabinoids found in the oil work in harmony with the human body's own endocannabinoid system making a positive effect for overall wellness. Hemp oil contains CBD -- a non-psychoactive compound of the plant. There are millions of hemp oil consumers around the world and this number is rapidly rising with an increasing number of reports and studies showing a variety of benefits of hemp oil.
ETST is focused on the science, research and studies of its High-Grade Hemp CBD Oil as a health and wellness, nutraceutical and dietary supplement. To assure the public that ETST provides the best High Grade Hemp CBD (Cannabidiol) Oil, we continue to focus on providing the public with sound scientific research and keeping the public informed on the progression of studies being done on our Hemp CBD products. ETST has engaged the expertise of a leading USA independent biological company and has been doing scientific research and studies with a University. Science is what will progress the future of ETST High Grade Hemp CBD (Cannabidiol) Oil and its products. Cannabidiol (CBD) is a naturally occurring constituent of industrial hemp oil. It is the most abundant non-psychoactive cannabinoid in hemp and is commonly used as a dietary supplement to support general wellness. ETST hemp derived, high CBD, full-spectrum phyto-cannabinoid oil blends are made from top quality, Grade-A European hemp cultivars, grown in pristine soil in choice European locations. ETST High Grade Hemp CBD oils are constantly analyzed for their purity and purity from potential contaminants. ETST encourages researching cannabidiol (CBD) from reliable informational sources to see what is being investigated and discussed about CBD oil. Numerous properties and benefits of CBD are being investigated at academic research centers in the United States and elsewhere. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.
ETST High Grade Hemp CBD (Cannabidiol): ETST High Grade Hemp CBD (Cannabidiol) Oil is formulated using a wide array of cutting-edge technologies. ETST's High Grade Hemp CBD Oil is all-natural and derived completely from the federally legal industrial hemp plant. Industrial Hemp (Hemp) is not marijuana and will not get you 'high' and it does not require a medical license of any kind to authorize purchase. It is lab tested multiple times during the manufacturing process, from seed to shelf. This also includes being tested for CBD content, other Cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and top quality. ETST believes that Hemp CBD Oil awareness today is where Omega 3 and Omega 6 fatty acids were 15 to 20 years ago. One of ETST's pertinent objectives is to help consumers Worldwide with their overall wellness through advanced formulations with its High Grade Hemp CBD (Cannabidiol) Oil and other cutting-edge nutraceuticals and dietary supplements. Hemp CBD Oil is poised to be the most renowned and effective natural compound and botanical alternative introduced to the nutritional and dietary supplement industry in decades. Consumers worldwide desperately need more effective and safe botanical alternatives to help them with their overall health and internal wellness.
About Earth Science Tech, Inc. (ETST): Earth Science Tech (www.earthsciencetech.com) is a publicly traded (ETST) unique Science based Biotechnology company focused on cutting edge Nutraceuticals, Bioceuticals, Phytoceuticals and Cosmeceuticals for the Health, Wellness and Alternative Medicine Markets to help improve the quality of life for Consumers Worldwide. ETST is also dedicated to providing Natural Alternatives to prescription medications through the use of its cutting edge Nutritional and Dietary Supplements. This may include products such as its High-Grade Hemp CBD (Cannabidiol) Oil, Vitamins, Minerals, Herbs, Botanicals, Personal Care Products, Homeopathies, Functional Foods and other products. These products may be in various formulations and delivery systems including (but not limited to) capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs. ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality and purity of High Grade Hemp CBD (Cannabidiol) Oil. ETST's primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties. The company is dedicated in offering its consumers the finest and purest quality All Natural-Organic Hemp CBD Oil while never compromising on quality. ETST High Grade Hemp CBD (Cannabidiol) Oil is classified as "food based" and therefore perfectly permissible in all 50 states and more than 40 countries. Cannabinoids (Cannabidiol/CBD) are natural constituents of the Hemp plant and CBD is derived from Hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD possesses no psychoactive qualities and presents a continuing stream of overwhelming evidence of significant Wellness benefits. With no psychoactive ingredient, Hemp CBD Oil is a ready-for-market Hemp-based Nutraceutical. The United States Food and Drug Administration (FDA) currently considers non-THC hemp based cannabinoids, including CBD, to be "food based" and therefore saleable. These new non-psychoactive CBD-rich hemp oil products that ETST has geared up to market and distribute are beyond reproach. CBD (cannabidiol), a naturally occurring constituent of the Industrial Hemp plant, promotes and supports the nutritional health of aging bodies in particular. Source: US Government Patent #6,630,507 "Cannabinoids as antioxidants and neuroprotectants." ETST does not grow, sell or distribute any substances that violate United States Law or the controlled substance act. ETST does sell and distribute hemp based products.
About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.
About Dr. Michel Aubé: Dr. Michel Aubé has wide-ranging expertise in the life sciences. As a microbiologist he furthered his graduate studies at Laval University, earning a Master’s degree in Molecular and Cell Biology as well as a PhD in Physiology-Endocrinology. In addition, he has 5 years postdoctoral experience in Immunology in three different labs at Montreal University. His scientific research in Sexually Transmitted Infections (STIs), Cancer and Stem Cell biology has been published in several prestigious medical journals. Dr. Aubé has received a number of Awards for Excellence from the Network for environmental health research and childhood diseases.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program.
FORWARD LOOKING DISCLAIMER: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml,specifically the most recent reports which identify important risk facts that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.
Earth Science Tech, Inc. (ETST)? Ft. Lauderdale, FL? Phone: +1(305) 615-2118? www.earthsciencetech.com? firstname.lastname@example.org